Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk of recurrence based on the OncotypeDX genomic test had better outcomes when ...

Key Leadership Appointments Bring New Skills and Capabilities to Organization EMERYVILLE, Calif., Dec. 13, 2024 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna) ...

AIDS Resource Alliance Inc. was recently selected as a second-year grant awardee of the AstraZeneca Foundation’s Creating Health Access for Next Generation Equity (CHANGE) program, which aims to ...

At 24 months, endocrine therapy appeared to have a more negative effect on HRQOL as measured by the global health status (GHS ...

The AstraZeneca PLC ADR AZN dropped 0.54% to $66.58 Friday, on what proved to be an all-around mixed trading session for the ...

Move over, AI. There's another fast-moving technology that's expected to generate massive financial gains in the second half of the 2020s. Quantum computing's reputation is growing as a tech ...

At least 29 patent suits were filed in the District of New Jersey in November, reflecting a jump from the rate of 18 suits ...

Action is the latest following Baldwin’s investigation into the extremely high prices these companies charge for inhalers ...

Omitting axillary SLNB does not impact outcomes in patients with early invasive breast cancer undergoing breast-conserving surgery, data suggest.

Americans with asthma and 16 million Americans with COPD need inhalers to breathe. Vermont Business Magazine Sen. Bernie Sanders (I-Vermont), Chairman of the Senate Com ...

The Dragons' Den star's podcast is increasingly focused on bizarre medical advice that could lead to ill health in those who ...

According to a report by Research and Markets, the international IT hardware market was valued at $130.86 billion in the ...